Nucleic Acid Construct Encoding Chimeric Rhodopsin - Restore Vision

Tue, 21 Apr 2026 13:30:11 +0000
Intellectual Property

USPTO granted Patent US12606606B2 to Restore Vision Inc. for a nucleic acid construct encoding a chimeric rhodopsin protein combining ion-transporting receptor rhodopsin with G protein-coupled receptor rhodopsin sequences. The patent contains 17 claims classified under C07K peptide chemistry and covers applications for preventing retinal diseases and enhancing visual function.